Oren Gilad
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Oren Gilad
Oren Gilad is recorded as CEO at Aprea Therapeutics, Inc. (APRE).
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-05-17–present
-
Aprea Therapeutics, Inc. (APRE)
SEC 8-K
Current2022-05-16–present
-
2022-01-01–2022-06-10
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aprea Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Richard Peters, M.D., Ph.D. Chairman, Board Member
- John Hamill CFO
- Scott M. Coiante CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Gabriela Gruia, M.D. Board Member
- Jean-Pierre Bizzari Board Member
- Marc Duey Board Member
Recent activity
No call appearances or filed executive changes recorded yet.